C12N 2740/10032
Use of virus as therapeutic agent, other than vaccine
Official title: Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
C12N2740/10032 (Use of virus as therapeutic agent, other than vaccine) appears on 8 US grants and 10 published applications in this corpus.
Search patents in C12N- Granted patents
- 8
- Published applications
- 10
- Assignees
- 6
- Inventors
- 13
- Latest grant
- 29 Aug 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 1 |
| 2016 | 0 | 1 |
| 2017 | 1 | 1 |
| 2018 | 1 | 1 |
| 2019 | 1 | 1 |
| 2020 | 2 | 1 |
| 2021 | 1 | 0 |
| 2022 | 0 | 1 |
| 2023 | 1 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods to treating hemoglobinopathies29 Aug 2023US 11,739,329 B2Children's Medical Center Corporation
- Compositions and methods to treating hemoglobinopathies21 Sep 2021US 11,124,794 B2Children's Medical Center Corporation
- Compositions and methods to treating hemoglobinopathies26 May 2020US 10,662,429 B2Children's Medical Center Corporation
- Viral vectors encoding multiple highly homologous non-viral polypeptides and the use of same4 Feb 2020US 10,550,176 B2Roger Williams Medical Center
- Compositions and methods to treating hemoglobinopathies14 May 2019US 10,287,588 B2Childrens's Medical Center Corporation
- A combination of succinate consuming microbiotas10 Sep 2026US 2026/0265680 A1
- Compositions and methods to treating hemoglobinopathies24 Feb 2022US 2022/0056453 A1Children's Medical Center Corporation
- Compositions and methods to treating hemoglobinopathies26 Nov 2020US 2020/0370048 A1Children's Medical Center Corporation
- Compositions and methods to treating hemoglobinopathies17 Oct 2019US 2019/0316136 A1Children's Medical Center Corporation
- Gene therapy vector system and prodrug genes31 May 2018US 2018/0147299 A1The Industry & Academic Cooperation in Chungnam National University (IAC)
Most cited
By later US patents
- Compositions and methods to treating hemoglobinopathies8US 10,287,588 B2Childrens's Medical Center Corporation · 2019
- Compositions and methods to treating hemoglobinopathies8US 10,662,429 B2Children's Medical Center Corporation · 2020
- Viral vectors encoding multiple highly homologus non-viral polypeptides and the use of same3US 9,206,440 B2Roger Williams Hospital · 2015
- Gene therapy vector system and prodrug genes2US 10,039,841 B2The Industry & Academic Cooperation in Chungnam National University (IAC) · 2018
- Viral vectors encoding multiple highly homologous non-viral polypeptides and the use of same1US 10,550,176 B2Roger Williams Medical Center · 2020